The eGFR test to determine the severity of a patient's CKD was added to the quality framework in 2006/7. The test boosts detection and treatment of patients at an early stage of CKD, and can pinpoint late-stage CKD patients who need dialysis, helping to cut emergency admissions.
But many laboratories had not adopted the test in time for 2006/7. GP leaders believe regional variations in availability of the test are to blame for low prevalence across the UK.
Scotland's prevalence as reported in quality data for 2006/7 is 1.8 per cent, compared with 2.2 in England and 2.3 in Northern Ireland.
GP leaders say the lower figure for Scotland is unrealistic, and reflects the slower roll-out of eGFR testing facilities compared with the rest of the UK.
National clinical director for kidney services Dr Donal O'Donogue said: 'The delay in implementing eGFR tests could explain low prevalence.'
Read full article - CKD patients at risk in eGFR test shortfall